Icon (ICLR) Change in Working Capital (2018 - 2026)
Icon's (ICLR) quarterly Change in Working Capital came in at $29.7 million in Q2 2026, down 77.87% year-over-year from $134.4 million in Q2 2025, and down 7.21% quarter-over-quarter from $32.0 million in Q1 2026.
Analysis
Icon (ICLR) Change in Working Capital (2018 - 2026) Analysis & Trends
Icon (ICLR) has reported Change in Working Capital for 7 consecutive years, with $29.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Working Capital fell 77.87% year-over-year to $29.7 million in Q2 2026; TTM through Jun 2026 was -$45.9 million, a 154.55% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 million, up 90.4% from the prior year.
- Change in Working Capital was $29.7 million for Q2 2026 at Icon, down from $32.0 million in the prior quarter.
- Over five years, Change in Working Capital peaked at $134.4 million in Q2 2025 and troughed at -$309.8 million in Q4 2023.
- A 5-year average of -$17.9 million and a median of -$9.5 million in 2022 frame the typical range for Change in Working Capital.
- Across the five-year window, Change in Working Capital sank 401.77% in 2022 and jumped 231.14% in 2023, its largest moves.
- Over 5 years, Change in Working Capital stood at -$9.5 million in 2022, then plunged by 3175.48% to -$309.8 million in 2023, then soared by 119.57% to $60.6 million in 2024, then sank by 81.84% to $11.0 million in 2025, then jumped by 170.12% to $29.7 million in 2026.
- The last three Change in Working Capital figures came in at $29.7 million (Q2 2026), $32.0 million (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 29.74 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.74 Mn |
| Mar 31, 2026 | 32.05 Mn |
| Dec 31, 2025 | 11.01 Mn |
| Sep 30, 2025 | -118.74 Mn |
| Jun 30, 2025 | 134.40 Mn |
| Mar 31, 2025 | -29.37 Mn |
| Dec 31, 2024 | 60.63 Mn |
| Sep 30, 2024 | -81.43 Mn |
| Jun 30, 2024 | 52.58 Mn |
| Mar 31, 2024 | -59.93 Mn |
| Dec 31, 2023 | -309.83 Mn |
| Sep 30, 2023 | -20.39 Mn |
| Jun 30, 2023 | 95.88 Mn |
| Mar 31, 2023 | 65.93 Mn |
| Sep 30, 2022 | -9.46 Mn |
| Jun 30, 2022 | -73.11 Mn |
| Mar 31, 2022 | -84.04 Mn |
| Sep 30, 2021 | -56.64 Mn |
| Jun 30, 2021 | 49.94 Mn |
| Mar 31, 2021 | 27.85 Mn |